| Michael Shamblott, Ph.D. Research Scientist, Kennedy Krieger Institute Dr. Michael Shamblott is a Research Scientist in the International Center for Spinal Cord Injury (ICSCI) at Kennedy Krieger Institute. He is also an Assistant Professor with the Johns Hopkins School of Medicine Department of Neurology and has joint appointment in the Johns Hopkins University Department of Chemical and Biological Engineering. |
Biographical Sketch:
Dr. Shamblott earned his Doctorate of Philosophy in Molecular and Cell Biology in 1995 from University Maryland Baltimore County. From 1989-1995 while at UMBC, he was a Research Assistant in the Department of Cellular and Molecular Biology. From there, he was a Post-Doctoral Fellow at the Johns Hopkins School of Medicine until 1999. In 2000 he was appointed as an Assistant Professor in the Johns Hopkins School of Medicine Department of Gynecology and Obstetrics. Joining the International Center of Spinal Cord Injury in 2008, Dr. Shamblott became a Research Scientist at the Hugo W. Moser Research Institute at Kennedy Krieger in the International Center for Spinal Cord Injury and switched primary appointments to the Department of Neurology at the Johns Hopkins School of Medicine.
Dr. Shamblott has received the Predoctoral Fellowship Award from the Office of Naval Research and the Alfred Blalock Research Award from Johns Hopkins University School of Medicine. In 2002 he received the Mary Tyler Moore & S. Robert Levine Clinical Career Development Award from the Juvenile Diabetes Research Foundation and in 2004 he was awarded the Giles W. and Elise G. Mead Foundation Award.
Dr. Shamblott has received the Predoctoral Fellowship Award from the Office of Naval Research and the Alfred Blalock Research Award from Johns Hopkins University School of Medicine. In 2002 he received the Mary Tyler Moore & S. Robert Levine Clinical Career Development Award from the Juvenile Diabetes Research Foundation and in 2004 he was awarded the Giles W. and Elise G. Mead Foundation Award.
Research Summary:
Dr. Shamblott’s research focuses on applications of human stem and progenitor cells. He is currently involved in research to develop cell therapies for type I (Juvenile) diabetes and spinal cord injury.
Recent Publications/Presentations:
Xiangcan Zhan, Ph.D, Christine Hill, B.A, Cory F. Brayton, D.V.M, Michael J. Shamblott, Ph.D. Cells derived from human umbilical cord blood support the long term growth of undifferentiated human embryonic stem cells. Cloning and Stem Cells. 2008 10(4):1-10
Locke, JE, Sun,Z, Warren,DS, Sheets,TP, Holzer,H, Shamblott,MJ, Montgomery,RA, Cameron,AM. Generation of humanized livers using embryoid body-derived stem cell transplant. Ann. Surg. 2008 248(3):487-93.
Hillel AT, Varghese S, Petsche J, Shamblott, MJ, Elisseeff JH.Embryonic germ cells Are capable of adipogenic differentiation in vitro and in vivo. Tissue Eng. A 2008.
Patterson, ES, Addis, RC, Shamblott, MJ, Gearhart, JD. Sox17 directly activates ZFP202 transcription during in vitro endoderm differentiation. Physiol Genomics. 2008. 34(3):277-84
Clark GO, Yochem RL, Axelman J, Sheets TP, Kaczorowski DJ, Shamblott, MJ. Glucose responsive insulin production from human embryonic germ (EG) cell derivatives. Biochem Biophys Res Commun. 2007 May 11;356(3):587-93.
Jansen JF, Shamblott, MJ, van Zijl PC, Lehtimaki KK, Bulte JW, Gearhart JD, Hakumaki JM. Stem cell profiling by nuclear magnetic resonance spectroscopy. Magn Reson Med. 2006 Sep;56(3):666-70.
Locke, JE, Sun,Z, Warren,DS, Sheets,TP, Holzer,H, Shamblott,MJ, Montgomery,RA, Cameron,AM. Generation of humanized livers using embryoid body-derived stem cell transplant. Ann. Surg. 2008 248(3):487-93.
Hillel AT, Varghese S, Petsche J, Shamblott, MJ, Elisseeff JH.Embryonic germ cells Are capable of adipogenic differentiation in vitro and in vivo. Tissue Eng. A 2008.
Patterson, ES, Addis, RC, Shamblott, MJ, Gearhart, JD. Sox17 directly activates ZFP202 transcription during in vitro endoderm differentiation. Physiol Genomics. 2008. 34(3):277-84
Clark GO, Yochem RL, Axelman J, Sheets TP, Kaczorowski DJ, Shamblott, MJ. Glucose responsive insulin production from human embryonic germ (EG) cell derivatives. Biochem Biophys Res Commun. 2007 May 11;356(3):587-93.
Jansen JF, Shamblott, MJ, van Zijl PC, Lehtimaki KK, Bulte JW, Gearhart JD, Hakumaki JM. Stem cell profiling by nuclear magnetic resonance spectroscopy. Magn Reson Med. 2006 Sep;56(3):666-70.
Contact Information:
Michael Shamblott, Ph.D.
Hugo W. Moser Research Institute at Kennedy Krieger
707 N. Broadway, Suite 520
Baltimore, MD 21205
(map & directions)
Telephone: (443)923-9227
Facsimile: (443)923-9215
Email: shamblott@kennedykrieger.org
Hugo W. Moser Research Institute at Kennedy Krieger
707 N. Broadway, Suite 520
Baltimore, MD 21205
(map & directions)
Telephone: (443)923-9227
Facsimile: (443)923-9215
Email: shamblott@kennedykrieger.org